In animal models Il-17 inhibition was able to improve AIH disease activity, moreover anti-IL-17 antibodies increased regulatory T-cells (Tregs) production and expansion from sera of AIH patients (109). This evidence concerns the gene IL17A and autoimmune hepatitis.